Role of implants in the treatment of diabetic macular edema: focus on the dexamethasone intravitreal implant
Zafer Cebeci, Nur KirDepartment of Ophthalmology, Istanbul Faculty of Medicine, Istanbul University, Capa, Istanbul, TurkeyAbstract: Diabetic macular edema (DME) is the leading cause of sight-threatening complication in diabetic patients, and several treatment modalities have been developed and eval...
Guardado en:
Autores principales: | Cebeci Z, Kir N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3d910ec09e4f4d8582c922d93f2ae167 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel PU, et al.
Publicado: (2015) -
The clinical utility of aflibercept for diabetic macular edema
por: Stewart MW
Publicado: (2015) -
Letter to the editor: dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Hall J
Publicado: (2015) -
Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
por: Pacella E, et al.
Publicado: (2013) -
SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
por: Seufert J
Publicado: (2015)